Download PDF
Novo Annual Review 2016
1 / 71
annual
review
2016
novo-ceo-2016-2.html
PageFlip Table of Contents:
1: 2016-review-annual-1.html
2: novo-ceo-2016-2.html
3: novo-2016-portfolio-3.html
4: novo-share-votes-4.html
5: novo-nordisk-group-5.html
6: novo-2016-investments-6.html
7: novo-nordisk-2016-7.html
8: novo-companies-life-8.html
9: novo-letter-2016-9.html
10: 2016-novo-report-10.html
11: novo-2016-investments-11.html
12: novo-investments-dkk-12.html
13: investments-2016-companies-13.html
14: novo-investments-companies-14.html
15: novo-novozymes-risk-15.html
16: novo-2016-ownership-16.html
17: investments-large-investment-17.html
18: investments-companies-large-18.html
19: allocation-number-geographical-19.html
20: data-ert-clinical-20.html
21: data-ert-solutions-21.html
22: synlab-laboratory-services-22.html
23: synlab-market-wimmer-23.html
24: com-www-pharmaceutical-24.html
25: announced-completed-received-25.html
26: novo-products-patients-26.html
27: companies-investments-novo-27.html
28: dkk-billion-companies-28.html
29: novo-usd-million-29.html
30: 2016-completed-listed-30.html
31: diseases-developing-treatment-31.html
32: cell-immune-cancer-32.html
33: immune-cells-cell-33.html
34: cells-immune-cell-34.html
35: tumour-antigen-immune-35.html
36: com-www-development-36.html
37: com-www-treatment-37.html
38: www-nasdaq-com-38.html
39: acquired-public-initial-39.html
40: novo-science-2016-40.html
41: biotech-companies-new-41.html
42: pharma-2016-novo-42.html
43: seeds-novo-43.html
44: nmd-pharma-treatment-44.html
45: corwave-pump-technology-45.html
46: project-focuses-clinical-46.html
47: developing-company-www-47.html
48: novo-2016-portfolio-48.html
49: financial-portfolio-investments-49.html
50: investment-portfolio-managers-50.html
51: portfolio-investment-financial-51.html
52: bonds-portfolio-credit-52.html
53: investments-dades-financial-53.html
54: novo-foundation-csr-54.html
55: novo-charter-companies-55.html
56: foundation-research-novo-56.html
57: foundation-nordisk-novo-57.html
58: nordisk-novo-2016-58.html
59: novozymes-sales-2016-59.html
60: nnit-services-clients-60.html
61: performance-company-group-61.html
62: investment-novo-science-62.html
63: novo-ventures-inc-63.html
64: novo-managing-chief-64.html
65: board-member-chairman-65.html
66: profit-2016-848-66.html
67: total-liabilities-assets-67.html
68: cash-shares-novo-68.html
69: page-69.html
70: photos-norddahl-jon-70.html
71: novo-3527-6510-71.html
